DK105206C - Fremgangsmåde til fremstilling af pyrimidincarboxylsyre-(4)-derivater eller pyrimidin-thiocarboxylsyre-(4)-derivater eller salte heraf. - Google Patents

Fremgangsmåde til fremstilling af pyrimidincarboxylsyre-(4)-derivater eller pyrimidin-thiocarboxylsyre-(4)-derivater eller salte heraf.

Info

Publication number
DK105206C
DK105206C DK43261AA DK43261A DK105206C DK 105206 C DK105206 C DK 105206C DK 43261A A DK43261A A DK 43261AA DK 43261 A DK43261 A DK 43261A DK 105206 C DK105206 C DK 105206C
Authority
DK
Denmark
Prior art keywords
derivatives
pyrimidine
salts
preparation
carboxylic acid
Prior art date
Application number
DK43261AA
Other languages
Danish (da)
English (en)
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Application granted granted Critical
Publication of DK105206C publication Critical patent/DK105206C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50—Three nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK43261AA 1960-02-02 1961-02-01 Fremgangsmåde til fremstilling af pyrimidincarboxylsyre-(4)-derivater eller pyrimidin-thiocarboxylsyre-(4)-derivater eller salte heraf. DK105206C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DET0017822 1960-02-02

Publications (1)

Publication Number Publication Date
DK105206C true DK105206C (da) 1966-09-05

Family

ID=7548727

Family Applications (1)

Application Number Title Priority Date Filing Date
DK43261AA DK105206C (da) 1960-02-02 1961-02-01 Fremgangsmåde til fremstilling af pyrimidincarboxylsyre-(4)-derivater eller pyrimidin-thiocarboxylsyre-(4)-derivater eller salte heraf.

Country Status (5)

Country Link
US (1) US3213090A (cs)
BE (3) BE599767A (cs)
CH (5) CH389635A (cs)
DK (1) DK105206C (cs)
SE (2) SE301319B (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3694441A (en) * 1971-03-05 1972-09-26 David William Dunwell Pyrimidotriazinone compounds
WO2006074147A2 (en) 2005-01-03 2006-07-13 Myriad Genetics, Inc. Nitrogen containing bicyclic compounds and therapeutical use thereof
US8309562B2 (en) * 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
WO2005003100A2 (en) 2003-07-03 2005-01-13 Myriad Genetics, Inc. 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis
US8258145B2 (en) * 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3056782A (en) * 1960-12-16 1962-10-02 Searle & Co Alkyl and alkoxy derivatives of 5, 7-dialkyl-6, 8-dioxo-5, 6, 7, 8-tetrahydro-1, 2, 3-triazino[5, 4-d]pyrimidines
US3056783A (en) * 1960-12-16 1962-10-02 Searle & Co 4-chloro-1, 2, 3-triazino[5, 4-d]pyrimidines

Also Published As

Publication number Publication date
CH431551A (de) 1967-03-15
SE301318B (cs) 1968-06-04
CH389635A (de) 1965-03-31
US3213090A (en) 1965-10-19
CH421972A (de) 1966-10-15
CH430736A (de) 1967-02-28
SE301319B (cs) 1968-06-04
BE599768A (fr) 1961-05-29
BE599769A (fr) 1961-05-29
BE599767A (fr) 1961-05-29
CH423785A (de) 1966-11-15

Similar Documents

Publication Publication Date Title
DK108006C (da) Fremgangsmåde til fremstilling af desacetyl-7-aminocephalosporansyre eller acylderivater eller salte deraf.
DK111445B (da) Fremgangsmåde til fremstilling af phenoxy- eller phenylmercaptosubstituerede monocarboxylsyreforbindelser eller salte heraf.
DK114559B (da) Fremgangsmåde til fremstilling af hydroxydiaminer eller syreadditionssalte deraf.
DK105206C (da) Fremgangsmåde til fremstilling af pyrimidincarboxylsyre-(4)-derivater eller pyrimidin-thiocarboxylsyre-(4)-derivater eller salte heraf.
DK106036C (da) Fremgangsmåde til fremstilling af diphenylacetamid-derivater eller salte deraf.
DK103564C (da) Fremgangsmåde til fremstilling af trihydroxamsyrer eller salte eller O-acylderivater deraf.
DK109867C (da) Fremgangsmåde til fremstilling af thioxanthenderivater eller syreadditionssalte deraf.
DK96113C (da) Fremgangsmåde til fremstilling af o-benzylphenoxy-β-1-piperidinopropan eller syreadditionssalte deraf.
DK102181C (da) Fremgangsmåde til fremstilling af piperidyliden-thioxanthen-derivater eller syreadditionssalte heraf.
DK97883C (da) Fremgangsmåde til fremstilling af 4-aza-thioxanthenderivater eller syreadditionssalte deraf.
DK105763C (da) Fremgangsmåde til fremstilling af 1-aza-thioxanthen-derivater eller syreadditionssalte heraf.
DK98246C (da) Fremgangsmåde til fremstilling af lysergolderivater eller syreadditionssalte heraf.
DK96742C (da) Fremgangsmåde til fremstilling af homothioxanthen-derivater eller syreadditionssalte heraf.
DK96175C (da) Fremgangsmåde til fremstilling af 9,10-dihyfroantracenderivater eller syreadditionssalte heraf.
DK96565C (da) Fremgangsmåde til fremstilling af 18-O-methyl-reserpsyremethylester eller salte deraf.
DK95742C (da) Fremgangsmåde til fremstilling af 18-O-methyl-reserpsyremethylester eller salte deraf.
DK97612C (da) Fremgangsmåde til fremstilling af nicotinsyreaminomethylamider eller syreadditionssalte deraf.
DK93456C (da) Fremgangsmåde til fremstilling af tryptaminderivater eller syreadditionssalte deraf.
DK96235C (da) Fremgangsmåde til fremstilling af nikotinsyreestere eller salte deraf.
DK95224C (da) Fremgangsmåde til fremstilling af nikotinsyreestere eller salte deraf.
DK99924C (da) Fremgangsmåde til fremstilling af 5-aryl-2-amino-2-oxazolin-4-oner eller tautomere eller syreadditionssalte heraf.
DK102861C (da) Fremgangsmåde til fremstilling af 5-aryl-2-amino-2-oxazolin-4-oner eller tautomere eller syreadditionssalte heraf.
DK101974C (da) Fremgangsmåde til fremstilling af 5-aryl-2-amino-2-oxazolin-4-oner eller tautomere eller syreadditionssalte heraf.
DK101175C (da) Fremgangsmåde til fremstilling af 5-aryl-2-amino-2-oxazolin-4-oner eller tautomere eller syreadditionssalte heraf.
DK101123C (da) Fremgangsmåde til fremstilling af phenylalaninderivater eller syreadditionssalte heraf.